Print this page    •   Back to Web version of article

Press Release
Reyataz and Sustiva Co-Pay Benefit Program

April 16, 2009

Bristol-Myers Squibb is launching a co-pay assistance program in April for eligible new and existing REYATAZ® (atazanavir) and SUSTIVA® (efavirenz) patients who are commercially insured and have high co-pays or co-insurance. We recognize that especially in this economic environment, out-of-pocket costs for HIV medicines may be prohibitive even for patients who have prescription drug benefits. This program reflects Bristol-Myers Squibb's ongoing commitment to helping patients who need our medicines to access them.

The REYATAZ and SUSTIVA Co-pay Benefit Program will allow eligible patients to save up to $200 of co-pay costs monthly, for up to a year. Patients will be responsible for the first $50 of out-of-pocket costs plus any amount over $250. To begin the enrollment process, eligible patients should speak to their healthcare professional to obtain a co-pay benefit card to take to the pharmacy with their prescription.

The co-pay benefit card is not valid in Massachusetts or for prescriptions purchased under Medicaid, Medicare, federal or state programs (including state prescription drug programs, or private indemnity or HMO insurance plans, which reimburse patients for the entire cost of the prescription drugs). First use must take place by December 31, 2009.

This Co-pay Benefit Program is for eligible commercially insured patients only. For patients living with HIV who are uninsured or underinsured, Bristol-Myers Squibb offers other programs to support access to medicines. Bristol-Myers Squibb provides our medicines free of charge to those who qualify through our Access Virology Patient Assistance Program and also participates in the pharmaceutical industry's Together RX Program.




This article was provided by Bristol-Myers Squibb Company. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art51300.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.